Fintel reports that on January 7, 2025, Evercore ISI Group downgraded their outlook for DENTSPLY SIRONA (NasdaqGS:XRAY) from ...

DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference. Management is scheduled ...

Everence Capital Management Inc. acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the 4th quarter, ...

Levi & Korsinsky, LLP notifies investors in Dentsply Sirona Inc. ("Dentsply" or the "Company") of a class action securities ...

In a report released today, Allen Lutz from Bank of America Securities maintained a Hold rating on DENTSPLY SIRONA (XRAY – Research Report).

( MENAFN - GlobeNewsWire - Nasdaq) Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Dentsply To Contact Him Directly ...

DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $18.85 which represents a slight increase of $0.24 or 1.29% from the prior close of $18.61. The stock opened at $18.51 and ...

DENTSPLY SIRONA (XRAY – Research Report) received a Hold rating and price target from Evercore ISI analyst Elizabeth Anderson CFA today. The ...

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Mizuho has recently initiated DENTSPLY SIRONA Inc (XRAY) stock to Neutral rating, as announced on December 4, 2024, according to Finviz. Earlier, on November 7, 2024, Leerink Partners had reduced the ...

The complaints allege that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to ...

You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected].